We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can see their share prices grow by huge amounts. Don't believe it? Then look at the ...

With its stock down 38% over the past three months, it is easy to disregard Compumedics (ASX:CMP). It is possible that the markets have ignored the company's differing financials and decided to ...

MELBOURNE, Australia--(BUSINESS WIRE)--Compumedics Limited (ASX: CMP), a world leading supplier of innovative medical technology for patient monitoring, has in collaboration with Beijing Fistar and ...

Compumedics delivers breakout performance in FY25 with record revenue and sales orders, a return to profitability, and accelerating growth in the US and SaaS segments. Compumedics (ASX:CMP) said the ...

Compumedics has received FDA approval to market Falcon, its second home sleep testing solution in the US, with potential to substantially boost its revenue. Falcon to complement Compumedics Somfit ...

Compumedics founder David Burton says brain imaging can rival the magnetic resonance imaging (MRI) market Having recently gained FDA approval, the company is eyeing the emerging US home sleep testing ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited projects a record-breaking year with over $50 million in sales orders and at least $46 million in revenue for FY24, driven by ...

Compumedics wins new Somfit sale worth about $1 million to one of the world’s leading pharmaceutical contract research organisations Somfit will be used in a series of pharmaceutical clinical trials ...

Compumedics (ASX:CMP) said the last financial year laid a stronger more scalable business model for FY26 and beyond with record sales orders of $63.4 million, up 22% on FY24. EBITDA increased to ~$3m, ...